Potential new anti-malarial drug identified at the Drug Discovery Unit, Dundee
A significant milestone in the development of a potential new antimalarial medicine has been reached by scientists at the University of Dundee, in partnership with the Medicines for Malaria Venture (MMV).
A compound developed in the Drug Discovery Unit at Dundee has been selected by MMV, following a positive recommendation by MMV’s Expert Scientific Advisory Committee, to enter preclinical development.